FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
A new vaccine to tackle Ebola will now be tested on people.
NPR has learned that the Department of Health and Human Services will not be finalizing its most aggressive attempt to eā¦
These snakes can go for months without eating, grow and shrink the size of their hearts and jump start their metabolism ā¦